EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

NanoViricides has signed a broad Memorandum of Understanding Agreement (MoU) with TheraCour encompassing all antiviral drugs developments on September 23, 2024, an important step that provides the ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

If you feel like your face is always flushed, red, or rosy, one of these conditions could be the reason why. The post 11 ...

Shingles responds well to antiviral treatment, and the pain is typically ... to see a healthcare provider if the rash gets close to your eye. Shingles is an infection in which the herpes zoster virus ...

Actor and advocate Brooke Shields says learning how to embrace aging and prioritize preventive health in her 50s feels "like ...

Interim Data from the Phase 1b portion of the study in participants with recurrent genital herpes is expected in ... regimens of ABI-5366 over a 29-day treatment interval in four cohorts.

AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...

Optimal management of recurrent HSV infection should ideally begin with counseling when first-episode HSV infection is diagnosed. At this stage, the patient should be educated regarding the nature ...

Herpes simplex virus (HSV) serotypes 1 and 2 establish lifelong infections that can produce reactivated pools of virus at mucosal sites where primary infections were initiated. No approved ...